Lameness after Lokivetmab (Cytopoint) in dogs
115 reports to the FDA describe lameness in dogs given Lokivetmab. That is 1.8% of all reports for this medicine, compared with 0.6% across reports for all dog medicines, so it is reported unusually often with this medicine.
115Reports
66%Marked serious
7.8%Recovered
10%Died or euthanised
12 daysTypical onset
Sponsored
How soon it started
How the animals did
Problems reported at the same time
Age of the animals
About this medicine
Lokivetmab controls allergic itch for 4–8 weeks per injection.
Products with this ingredient include Cytopoint. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.
Questions owners ask
- Can Lokivetmab cause lameness in dogs?
- 115 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
- How soon after a dose was it reported?
- In half of the reports with dates, it started within 12 days of the first dose.
- What should I do?
- Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).
Lameness with similar medicines
- Lameness after Bedinvetmab (Librela) 810 reports · 4.1% of its reports
All reported side effects of Lokivetmab in dogs · Medicines most reported with lameness